Human GIPR Full-Length Bioactive Membrane Protein (HDFP111)
- SKU:
- HDFP111
- Product Type:
- Recombinant Protein
- Protein Type:
- Full-Length Bioactive Membrane Protein
- Species:
- Human
- Uniprot:
- P48546
Frequently bought together:
Description
system_update_altDatasheet
| Product name | Human GIPR full length protein-synthetic nanodisc |
| Size: | 10ug |
| Product SKU: | HDFP111 |
| Product Category | Full Length Transmembrane Proteins |
| Target: | GIPR |
| Uniprot: | P48546 |
| Description: | Human GIPR full length protein-synthetic nanodisc |
| Molecular Weight: | The human full length GIPR protein has a MW of 53 kDa |
| Protein Family: | Druggable Genome, GPCR, Transmembrane |
| Protein Pathways: | Neuroactive ligand-receptor interaction |
| Storage & Shipping: | Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature. |
| Synonyms: | PGQTL2 |
| Expression System: | HEK293 |
| Formulation: | Lyophilized from nanodisc solubilization buffer (20 mM Tris-HCl, 150 mM NaCl, pH 8.0). Normally 5% - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions. |
| Background: | This gene encodes a G-protein coupled receptor for gastric inhibitory polypeptide (GIP), which was originally identified as an activity in gut extracts that inhibited gastric acid secretion and gastrin release, but subsequently was demonstrated to stimulate insulin release in the presence of elevated glucose. Mice lacking this gene exhibit higher blood glucose levels with impaired initial insulin response after oral glucose load. Defect in this gene thus may contribute to the pathogenesis of diabetes. [provided by RefSeq, Oct 2011] |
| Delivery: | 3-4 weeks |
| Usage | Research use only |
